基本信息
views: 47
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Prof Berger was trained as a biochemist at Leibniz University and Medical School in Hannover, Germany; the Massachusetts Institute of Technology in Cambridge, USA; and ETH Zurich in Switzerland. After holding group leader posts at ETH (2005) and EMBL (2007), he was appointed professor of biochemistry and chemistry at the University of Bristol, UK in 2014. In 2017, he became director of the Bristol Synthetic Biology Centre (BrisSynBio) and co-director of the Bristol BioDesign Institute (BBI). Since 2019, he has been founding and managing director of the Max Planck-Bristol Centre for Minimal Biology and investigator of the European Research Council (ERC).
Prof Berger researches essential proteins in human health and disease, creates synthetic vaccines, and pioneered synthetic viral nanosystems for DNA delivery, genome engineering and complex biologics production. The tools he developed are accelerating R&D in academia and industry worldwide. He holds international patents for protein and DNA technologies, has published prolifically in leading periodicals, co-founded four biotech companies, and received numerous distinctions for his innovative research, including the Swiss Technology Award, W.A. DeVigier Foundation Award, an OBN UK Ltd Business Award, and a Wellcome Trust Senior Investigator Award. in 2020, Prof Berger’s team discovered a druggable pocket in the SARS-CoV-2 spike protein as well as a drug that has promise for treating COVID-19. In 2022, Prof Berger was elected Fellow of the Academy of Medical Sciences of the UK.
Research Interests
Papers共 206 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nucleic acids researchno. 6 (2024): 3450-3468
S. Basu,O. Shukron, D. Hall,P. Parutto,A. Ponjavic, D. Shah, W. Boucher,D. Lando,W. Zhang, N. Reynolds, L. H. Sober, A. Jartseva,
NATURE STRUCTURAL & MOLECULAR BIOLOGYno. 2 (2024): 390-390
Biomedicine & Pharmacotherapy (2024): 116439-116439
S. Basu,O. Shukron, D. Hall,P. Parutto,A. Ponjavic, D. Shah, W. Boucher,D. Lando,W. Zhang, N. Reynolds, L. H. Sober, A. Jartseva,
Nature Structural & Molecular Biologyno. 2 (2024): 390-390
CLINICAL KIDNEY JOURNALno. 5 (2024): sfae119-sfae119
Holly Baum,Marianna Santopaolo,Ore Francis, Katrina Entwistle,Elizabeth Oliver,Benjamin Hitchings, Divya Diamond,Amy Thomas,Ruth Mitchell,Milla Kibble,Kapil Gupta,Natalie Di Bartolo,
medrxiv(2024)
Communications medicineno. 1 (2023): 37-37
Antibody therapeuticsno. 4 (2023): 277-297
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn